Christopher August Lucchesi (Christopher A Lucchesi, Christopher Lucchessi)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Binding Protein

Radical Prostatectomy

Dna Damage Response

Top Venues

International journal of molecular sciences

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Jin Zhang, Xiangmudong Kong, Hee Jung Yang, Shakur Mohibi, Christopher August Lucchesi, Weici Zhang, Xinbin Chen
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion. Cancers 16 (1) (2024)
Jin Zhang, Xiangmudong Kong, Hee Jung Yang, Shakur Mohibi, Christopher August Lucchesi, Weici Zhang, Xinbin Chen
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion. Cancers 16 (1) (2024)
Demitria M Vasilatis, Neelu Batra, Christopher August Lucchesi, Christine J Abria, Eva-Maria Packeiser, Hugo Murua Escobar, Paramita M Ghosh
Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines. International journal of molecular sciences 25 (16) (2024)
Jin Zhang, Xiangmudong Kong, Hee Jung Yang, Shakur Mohibi, Christopher August Lucchesi, Weici Zhang, Xinbin Chen
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion. Cancers 16 (1) (2024)
Demitria M Vasilatis, Neelu Batra, Christopher August Lucchesi, Christine J Abria, Eva-Maria Packeiser, Hugo Murua Escobar, Paramita M Ghosh
Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines. International journal of molecular sciences 25 (16) (2024)
Jin Zhang, Xiangmudong Kong, Hee Jung Yang, Shakur Mohibi, Christopher August Lucchesi, Weici Zhang, Xinbin Chen
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion. Cancers 16 (1) (2024)
Demitria M Vasilatis, Christopher August Lucchesi, Paramita M Ghosh
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants. Biomedicines 11 (4) (2023)
Demitria M Vasilatis, Christopher August Lucchesi, Paramita M Ghosh
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants. Biomedicines 11 (4) (2023)
Christopher August Lucchesi, Demitria M Vasilatis, Saisamkalpa Mantrala, Thenappan Chandrasekar, Maria Mudryj, Paramita M Ghosh
Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies. International journal of molecular sciences 24 (14) (2023)
Demitria M Vasilatis, Christopher August Lucchesi, Paramita M Ghosh
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants. Biomedicines 11 (4) (2023)
Christopher August Lucchesi, Xiangmudong Kong, Mingchun Gao, Jared T Shaw, Xinbin Chen
Identification of a First-in-Class Small Molecule Inhibitor of the eIF4E-RBM38 Complex that Enhances wild-type p53 Protein Translation for Tumor Growth Suppression. Molecular cancer therapeutics (2023)
Christopher August Lucchesi, Xiangmudong Kong, Buyong Ma, Ruth Nussinov, Xinbin Chen
Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a. Cancer research 81 (7) (2021)
Wenqiang Sun, Kyra Laubach, Christopher August Lucchesi, Yanhong Zhang, Mingyi Chen, Xiangmudong Kong, Xinbin Chen
Fine-tuning p53 activity by modulating the interaction between eukaryotic translation initiation factor eIF4E and RNA-binding protein RBM38. Genes & development 35 (7-8) (2021)